Literature DB >> 11223914

Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.

S M Yatin1, M Yatin, S Varadarajan, K B Ain, D A Butterfield.   

Abstract

The polyamines, relatively low-molecular-weight aliphatic compounds, are the main inducers of eukaryotic cell growth and proliferation. Although polyamine requirements for cell growth are well defined, their role is still enigmatic. We have previously reported that amyloid beta-peptide (A beta), the main constituent of senile plaques in Alzheimer's disease (AD) brain, is toxic to neurons through a free radical-dependent oxidative stress mechanism and that A beta(1--42), the principal form of A beta in AD brain, causes an increase in polyamine metabolism manifested by up-regulated polyamine uptake and increased ornithine decarboxylase (ODC) activity. Both effects were prevented by the free radical scavenger vitamin E. Spermine has been reported to function directly as a free radical scavenger. In the current study, we aimed to address whether up-regulation of polyamine metabolism is a defense against, or a result of, A beta-induced oxidative stress by investigating the capability of spermine to quench A beta-associated free radicals in solution and to assert a protective function of spermine in neuronal culture against A beta. Pretreatment of cultured neurons with spermine prior to A beta exposure failed to prevent A beta-induced cell death. Indeed, A beta plus spermine added to cultured neurons was even more neurotoxic than either agent alone. Additionally, inhibition of the polyamine synthesis by difluoromethylornithine (DFMO) did not protect cells from A beta-induced free radical toxicity, and stimulation of the synthesis of putrescine and spermine by the aminopropyltransferase inhibitor S-adenosyl-1,8-diamino-thiooctane (AdoDATO), rather, further enhanced A beta-induced toxicity. Although spermine is capable of scavenging free radicals generated by A beta in solution as measured by electron paramagnetic resonance (EPR) spectroscopy, the up-regulated transport of exogenously added spermine together with A beta may lead to overaccumulation of a cellular spermine pool, with resulting enhanced neurotoxicity. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223914     DOI: 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  23 in total

Review 1.  Polyamines in mammalian pathophysiology.

Authors:  Francisca Sánchez-Jiménez; Miguel Ángel Medina; Lorena Villalobos-Rueda; José Luis Urdiales
Journal:  Cell Mol Life Sci       Date:  2019-06-21       Impact factor: 9.261

2.  Extracellular spermine exacerbates ischemic neuronal injury through sensitization of ASIC1a channels to extracellular acidosis.

Authors:  Bo Duan; Yi-Zhi Wang; Tao Yang; Xiang-Ping Chu; Ye Yu; Yu Huang; Hui Cao; Jillian Hansen; Roger P Simon; Michael X Zhu; Zhi-Gang Xiong; Tian-Le Xu
Journal:  J Neurosci       Date:  2011-02-09       Impact factor: 6.167

Review 3.  The Chemistry of Neurodegeneration: Kinetic Data and Their Implications.

Authors:  Matic Pavlin; Matej Repič; Robert Vianello; Janez Mavri
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

Review 4.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

5.  The impact of spermine synthase (SMS) mutations on brain morphology.

Authors:  Shelli R Kesler; Charles Schwartz; Roger E Stevenson; Allan L Reiss
Journal:  Neurogenetics       Date:  2009-03-07       Impact factor: 2.660

Review 6.  Protein phosphorylation and APP metabolism.

Authors:  Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

7.  Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease.

Authors:  Mark H Chin; Wei-Jun Qian; Haixing Wang; Vladislav A Petyuk; Joshua S Bloom; Daniel M Sforza; Goran Laćan; Dahai Liu; Arshad H Khan; Rita M Cantor; Diana J Bigelow; William P Melega; David G Camp; Richard D Smith; Desmond J Smith
Journal:  J Proteome Res       Date:  2008-02       Impact factor: 4.466

8.  Cellular polyamines promote amyloid-beta (Aβ) peptide fibrillation and modulate the aggregation pathways.

Authors:  Jinghui Luo; Chien-Hung Yu; Huixin Yu; Rok Borstnar; Shina C L Kamerlin; Astrid Gräslund; Jan Pieter Abrahams; Sebastian K T S Wärmländer
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

Review 9.  The glutamatergic system and Alzheimer's disease: therapeutic implications.

Authors:  D Allan Butterfield; Chava B Pocernich
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  Polyamines: Functions, Metabolism, and Role in Human Disease Management.

Authors:  Narashans Alok Sagar; Swarnava Tarafdar; Surbhi Agarwal; Ayon Tarafdar; Sunil Sharma
Journal:  Med Sci (Basel)       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.